Bioventus Inc.BVSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P25
Within normal range
vs 5Y Ago
-8.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -11.19% |
| 2024 | 1.44% |
| 2023 | -43.63% |
| 2022 | 25.29% |
| 2021 | 69.96% |
| 2020 | 1.33% |
| 2019 | 36.57% |
| 2018 | -0.01% |
| 2017 | 2.48% |
| 2016 | -46.43% |